| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/06/2023 | 3031.52% | Dawson James | → $6 | Initiates Coverage On | → Buy |
| 11/16/2020 | 56.58% | HC Wainwright & Co. | $0.5 → $0.3 | Maintains | Buy |
| 06/17/2020 | 160.96% | HC Wainwright & Co. | $0.65 → $0.5 | Maintains | Buy |
What is the target price for Zomedica (ZOM)?
The latest price target for Zomedica (AMEX: ZOM) was reported by Dawson James on January 6, 2023. The analyst firm set a price target for $6.00 expecting ZOM to rise to within 12 months (a possible 3031.52% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zomedica (ZOM)?
The latest analyst rating for Zomedica (AMEX: ZOM) was provided by Dawson James, and Zomedica initiated their buy rating.
When is the next analyst rating going to be posted or updated for Zomedica (ZOM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zomedica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zomedica was filed on January 6, 2023 so you should expect the next rating to be made available sometime around January 6, 2024.
Is the Analyst Rating Zomedica (ZOM) correct?
While ratings are subjective and will change, the latest Zomedica (ZOM) rating was a initiated with a price target of $0.00 to $6.00. The current price Zomedica (ZOM) is trading at is $0.19, which is within the analyst's predicted range.
